0001127602-19-023019.txt : 20190628 0001127602-19-023019.hdr.sgml : 20190628 20190628161735 ACCESSION NUMBER: 0001127602-19-023019 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190627 FILED AS OF DATE: 20190628 DATE AS OF CHANGE: 20190628 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NABEL ELIZABETH G CENTRAL INDEX KEY: 0001619929 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38753 FILM NUMBER: 19929635 MAIL ADDRESS: STREET 1: BRIGHAM AND WOMEN'S HOSPITAL STREET 2: 75 FRANCIS ST CITY: BOSTON STATE: MA ZIP: 02115 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Moderna, Inc. CENTRAL INDEX KEY: 0001682852 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 813467528 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6177146500 MAIL ADDRESS: STREET 1: 200 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Moderna Therapeutics, Inc. DATE OF NAME CHANGE: 20160822 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2019-06-27 0001682852 Moderna, Inc. MRNA 0001619929 NABEL ELIZABETH G C/O MODERNA, INC. 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 1 Stock Option (Right to Buy) 14.34 2019-06-27 4 A 0 54660 0 A 2029-06-27 Common Stock 54660 54660 D This option will become fully vested and exercisable on the earlier of June 27, 2020, or the next Annual Meeting of Stockholders, subject to the recipient's continued service. /s/ Jeffrey Cerio, as Attorney-in-Fact 2019-06-28